Concepedia

I Tepler

IT

14

Publications

946

Citations

11

H-Index

1988

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Howard Hughes Medical Institute

Beth Israel Deaconess Hospital

Brigham and Women's Hospital

I Tepler is an author at Dana-Farber Cancer Institute specializing in immunology, molecular immunology, and signal transduction.

Top concepts

Publications per year

1988–1997

14

Publications

14

Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer

AD Elias, Lois Ayash, KC Anderson et al. · Blood · 1992 · 259 citations · Full text

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.

Lois Ayash, Anthony Elias, Catherine Wheeler et al. · Journal of Clinical Oncology · 1994 · 141 citations

Human and rat mast cell high-affinity immunoglobulin E receptors: characterization of putative alpha-chain gene products.

Akira Shimizu, I Tepler, Philip N. Benfey et al. · Proceedings of the National Academy of Sciences · 1988 · 112 citations · Full text

, , +15

Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes.

P K Pattengale, Timothy A. Stewart, A Leder et al. · PubMed · 1989 · 100 citations · Full text

Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.

I Tepler, S A Cannistra, Emil Frei et al. · Journal of Clinical Oncology · 1993 · 84 citations

Rows per page

1–5 of 14